ImaRx Therapeutics Inc: SonoLysis™
| SonoLysis™is a program is comprised of their microbubbles, ultrasound and the thrombolytic drug tPA to enhance thromboembolic theraphy for ischemia. Their agent is based on a lipid shell encapsulating an inert biocompatible gas. It is not yet approved for sale. |
Company Web Site:SonoLysis™ |
| Ultrasound Contrast Agents | |
| Approved | In Development |
| Bracco: SonoVue® | Acusphere, Inc™: magify™ |
| Bristol-Myers Squibb: DEFINITY® | AION Diagnostics, Inc: modified porous silicon |
| GE: OPTISON™ | Targeson, LLC: Targestar™ |
| IMACOR: Imagent | ImaRx Therapeutics, Inc: SonoLysis™ |
| POINT Biomedical: CARDIOsphere™ | |
